THE ROLE OF SCHEDULE DEPENDENCY OF 5-FLUOROURACIL LEUCOVORIN COMBINATIONS IN ADVANCED COLORECTAL-CANCER

被引：0
|
作者：
SCHOBER, C [1 ]
BOKEMEYER, C [1 ]
STAHL, M [1 ]
WILKE, HJ [1 ]
SCHMOLL, HJ [1 ]
POLIWODA, H [1 ]
机构：
[1] UNIV ESSEN GESAMTHSCH KLINIKUM,GERMAN CANC CTR,W-4300 ESSEN 1,GERMANY
来源：
SEMINARS IN ONCOLOGY | 1992年 / 19卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：131 / 135
页数：5
相关论文
共 50 条
  • [41] 5-FLUOROURACIL PLUS TAUROMUSTINE IN ADVANCED COLORECTAL-CANCER - UNEXPECTED NEGATIVE RESULTS
    TAAL, BG
    HUININK, WWT
    FRANKLIN, HR
    MCVIE, JG
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (07) : 856 - 856
  • [42] CHEMOTHERAPY OF ADVANCED COLORECTAL-CANCER - A RANDOMIZED TRIAL OF SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL
    MACKINTOSH, J
    COATES, A
    SWANSON, C
    RAGHAVAN, D
    TATTERSALL, MHN
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 210 - 212
  • [43] PHASE-II STUDY OF 5-FLUOROURACIL PLUS LEUCOVORIN AND INTERFERON ALPHA-2B IN ADVANCED COLORECTAL-CANCER
    SOBRERO, A
    NOBILE, MT
    GUGLIELMI, A
    MORI, A
    ASCHELE, C
    BOLLI, E
    TIXI, L
    GALLO, L
    PARODI, GC
    BRUZZI, P
    BREMA, F
    ROSSO, R
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) : 850 - 852
  • [44] ACTIVITY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER CLINICALLY RESISTANT TO BOLUS 5-FLUOROURACIL
    MORI, A
    BERTOGLIO, S
    GUGLIELMI, A
    ASCHELE, C
    BOLLI, E
    TIXI, L
    ROSSO, R
    SOBRERO, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (02) : 179 - 180
  • [45] RANDOMIZED COMPARISON OF FLUOROURACIL AND LEUCOVORIN THERAPY VERSUS FLUOROURACIL, LEUCOVORIN, AND CISPLATIN THERAPY IN PATIENTS WITH ADVANCED COLORECTAL-CANCER
    SCHEITHAUER, W
    DEPISCH, D
    KORNEK, G
    PIDLICH, J
    ROSEN, H
    KARALL, M
    PROCHASKA, M
    ERNST, A
    SEBESTA, C
    ECKHARDT, S
    CANCER, 1994, 73 (06) : 1562 - 1568
  • [46] Is oral tegafur with leucovorin equivalent to intravenous 5-fluorouracil and leucovorin in colorectal cancer?
    Friberg, G.
    Schilsky, R. L.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (05): : 240 - 241
  • [47] Is oral tegafur with leucovorin equivalent to intravenous 5-fluorouracil and leucovorin in colorectal cancer?
    Gregory Friberg
    Richard L Schilsky
    Nature Clinical Practice Oncology, 2006, 3 : 240 - 241
  • [48] Trimetrexate as a biochemical modulator of 5-fluorouracil and leucovorin in colorectal cancer
    Punt, CJA
    SEMINARS IN ONCOLOGY, 2000, 27 (05) : 88 - 90
  • [49] Randornised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer
    Nogué, M
    Salud, A
    Batiste-Alentorn, E
    Saigí, E
    Losa, F
    Cirera, L
    Méndez, M
    Campos, JM
    Galan, A
    Escudero, P
    Arcusa, A
    Manzano, H
    de Mendizábal, EV
    de Olaguer, JP
    Boleda, M
    Guasch, I
    Vicente, P
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (15) : 2241 - 2249
  • [50] INTRAPORTAL 5-FLUOROURACIL FOR COLORECTAL-CANCER - THE AXIS TRIAL
    GARTEN, L
    STENNING, S
    GRAY, R
    LANCET, 1992, 340 (8825): : 985 - 985
12345